Table 4.
Association of habitual nighttime sleep duration with post-COVID among those who received two mRNA vaccine doses and exhibited persistent sleep duration patterns between before the pandemic and during the pandemic.
Nighttime sleep duration | n | Post-COVID, n (%) | OR [95%-CI] | |
---|---|---|---|---|
Unadjusted | Adjusteda | |||
6–9 h | 4512 | 868 (19.2) | 1 [ref] | 1 [ref] |
<6 h | 564 | 143 (25.4) | 1.43 [1.16, 1.75] | 1.59 [1.24, 2.03] |
>9 h | 92 | 30 (32.6) | 2.03 [1.31, 3.16] | 1.18 [0.70, 1.97] |
aAdjusted for: participants’ age, gender, ethnicity, test positivity status, time elapsed since first mRNA vaccination, smoking status, weekly alcohol consumption, educational level, marital status, living area, the weekly physical activity level score, presence of obesity/hypertension/diseases of the circulatory system/diabetes mellitus/diseases of respiratory system/neuropsychiatric disorders/other diseases.